Professor Sarfaraz Niazi of Washington State University Files FDA Citizen Petition Seeking New Pathway to Make High-Cost Medicines More Accessible Worldwide

<p>The petition requests that the FDA broaden the scientific principles supporting generics and biosimilars to encompass all eligible FDA-approved drugs and biological products. This initiative has the potential to foster competition for some of the most expensive therapies globally once...</p>